The Leadership Team at Mythic Therapeutics is responsible for setting the strategic direction and oversight of the company’s innovative research and development initiatives. This team, comprising key executives such as the Chief Scientific Officer and COO, collaborates to drive the advancement of FateControl technology, ensuring that Antibody Drug Conjugates are effectively harnessed to target cancer cells while minimizing harm to normal tissues. Their leadership fosters a culture of innovation and scientific excellence critical for the company's mission to transform cancer treatment.
View all